Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors

Nature Genetics

Volumn 16, Issue 3, 1997, Pages 270-276

  Snyder, R O ^a   Miao, C H ^a   Patijn, G A ^a   Spratt, S K ^a   Danos, O ^a   Nagy, D ^a   Gown, A M ^a   Winther, B ^a   Meuse, L ^a   Cohen, L K ^a   Thompson, A R ^a   Kay, M A ^a  

^a CELL GENESYS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR 9 CONCENTRATE; COMPLEMENTARY DNA; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHROPATHY; ARTICLE; BLEEDING TENDENCY; BLOOD TRANSFUSION; CONTROLLED STUDY; DISABILITY; DOG; GENE TRANSFER; HEMOPHILIA; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS GENE; X CHROMOSOME RECESSIVE DISORDER;

ALANINE TRANSAMINASE; ANIMALS; CELL DIVISION; DEPENDOVIRUS; DNA, ANTISENSE; FACTOR IX; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEMOPHILIA B; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER; MICE; RNA, MESSENGER; TYROSINE 3-MONOOXYGENASE;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE; ANIMALIA; CANIS FAMILIARIS;

EID: 0030997346     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng0797-270     Document Type: Article

References (36)